<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39454514</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-035X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of infection and public health</Title><ISOAbbreviation>J Infect Public Health</ISOAbbreviation></Journal><ArticleTitle>Retrospective analysis of COVID-19 clinical and laboratory data: Constructing a multivariable model across different comorbidities.</ArticleTitle><Pagination><StartPage>102566</StartPage><MedlinePgn>102566</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2024.102566</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1876-0341(24)00300-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The clinical pathogenesis of COVID-19 necessitates a comprehensive and homogeneous study to understand the disease mechanisms. Identifying clinical symptoms and laboratory parameters as key predictors can guide prognosis and inform effective treatment strategies. This study analyzed comorbidities and laboratory metrics to predict COVID-19 mortality using a homogeneous model.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A retrospective cohort study was conducted on 7500 COVID-19 patients admitted to Rasoul Akram Hospital between 2022 and 2022. Clinical and laboratory data, along with comorbidity information, were collected and analyzed using advanced coding, data alignment, and regression analyses. Machine learning algorithms were employed to identify relevant features and calculate predictive probability scores.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The frequency and mortality rates of COVID-19 among males (19.3 %) were higher than those among females (17 %) (p = 0.01, OR = 0.85, 95 % CI = 0.76-0.96). Cancer (p &lt; 0.05, OR = 1.9, 95 % CI = 1.48-2.4) and Alzheimer's (p &lt; 0.05, OR = 2.36, 95 % CI = 1.89-2.9) were the two most common comorbidities associated with long-term hospitalization (LTH). Kidney disease (KD) was identified as the most lethal comorbidity (45 % of KD patients) (OR = 5.6, 95 % CI = 5.05-6.04, p &lt; 0.001). Age &gt; 55 was the most predictive parameter for mortality (p &lt; 0.001, OR = 6.5, 95 % CI = 1.03-1.04), and the CT scan score showed no predictive value for death (p &gt; 0.05). WBC, Cr, CRP, ALP, and VBG-HCO3 were the most significant critical data associated with death prediction across all comorbidities (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">COVID-19 is particularly lethal for elderly adults; thus, age plays a crucial role in disease prognosis. Regarding death prediction, various comorbidities rank differently, with KD having a significant impact on mortality outcomes.</AbstractText><CopyrightInformation>Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shokrollahi Barough</LastName><ForeName>Mahdieh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine Iran University of Medical Sciences, Tehran, Iran; Immunology research center institute of immunology and infectious diseases Iran University of Medical Sciences, Tehran, Iran; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darzi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunesian</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amini Panah</LastName><ForeName>Danesh</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Antimicrobial resistance research center, institute of immunology and infectious diseases Iran University of Medical Sciences, Tehran, Iran; Department of Infectious Disease, School of Medicine, Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghane</LastName><ForeName>Yekta</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Antimicrobial resistance research center, institute of immunology and infectious diseases Iran University of Medical Sciences, Tehran, Iran; Department of Infectious Disease, School of Medicine, Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mottahedan</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakinehpour</LastName><ForeName>Sohrab</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Radiation Sciences Department, School of paramedicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowsarirad</LastName><ForeName>Tahereh</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Radiation Sciences Department, School of paramedicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseini-Farjam</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amirzargar</LastName><ForeName>Mohammad Reza</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Hematology &amp; Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehghani</LastName><ForeName>Samaneh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahriyary</LastName><ForeName>Fahimeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Hematology &amp; Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabiri</LastName><ForeName>Mohammad Mahdi</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>School of engineering, the University of Warwick, Coventry, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nojomi</LastName><ForeName>Marzieh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saraygord-Afshari</LastName><ForeName>Neda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology, Faculty of Allied Medical sciences Iran University of Medical sciences, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostofi</LastName><ForeName>Seyedeh Ghazal</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yassin</LastName><ForeName>Zeynab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Antimicrobial resistance research center, institute of immunology and infectious diseases Iran University of Medical Sciences, Tehran, Iran. Electronic address: yassin.z@iums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mojtabavi</LastName><ForeName>Nazanin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine Iran University of Medical Sciences, Tehran, Iran; Immunology research center institute of immunology and infectious diseases Iran University of Medical Sciences, Tehran, Iran. Electronic address: mojtabavi.n@iums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect Public Health</MedlineTA><NlmUniqueID>101487384</NlmUniqueID><ISSNLinking>1876-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Comorbidity</Keyword><Keyword MajorTopicYN="N">Feature selection</Keyword><Keyword MajorTopicYN="N">Laboratory data</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest I, Nazanin Mojtabavi, on behalf of all co-authors, hereby declare that there is no conflict of interest regarding the research presented in this manuscript entitled "[Retrospective Analysis of COVID-19 Clinical and Laboratory Data: Constructing a Multivariable Model Across Different Comorbidities]". I affirm that neither myself nor any of my co-authors have any financial, personal, or professional interests that could influence the interpretation or presentation of the research findings contained within this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>18</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39454514</ArticleId><ArticleId IdType="doi">10.1016/j.jiph.2024.102566</ArticleId><ArticleId IdType="pii">S1876-0341(24)00300-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle>